POLYMER DERIVATIVES AND POLYETHYLENE GLYCOL DERIVATIVES FOR USE IN THE MANUFACTURE OF THERAPEUTIC AND DIAGNOSTIC AGENTS AND IMAGING AGENTS FOR DIAGNOSTIC PURPOSES; POLYMER DERIVATIVES AND POLYETHYLENE GLYCOL DERIVATIVES FOR USE IN THE MANUFACTURE OF COSMETIC AND PHARMACEUTICAL PREPARATIONS AND SUBSTANCES; POLYMER BEADS FOR USE IN MANUFACTURING; POLYALKYLENE GLYCOLS FOR USE IN THE MANUFACTURE OF THERAPEUTIC AND DIAGNOSTIC AGENTS AND IMAGING AGENTS FOR DIAGNOSTIC PURPOSES; LIPOSOMES, PROTEINS AND PEPTIDES FOR USE IN THE MANUFACTURE OF PHARMACEUTICALS; DIAGNOSTIC AGENTS AND REAGENTS FOR MEDICAL RESEARCH USE; POLYMER MODIFIED COMPOUNDS FOR USE IN THE MANUFACTURE OF THERAPEUTIC AND DIAGNOSTIC AGENTS; IMAGING AGENTS FOR DIAGNOSTIC PURPOSES

PHARMACEUTICAL AND VETERINARY PREPARATIONS AND SUBSTANCES; NAMELY, PROTEINS, PEPTIDES, AMINO ACIDS AND THEIR DERIVATIVES, NAMELY, ANTIBODIES AND FRAGMENTS THEREOF; CYTOKINES AND DERIVATIVES OR FRAGMENTS THEREOF, NAMELY, THE INTERLEUKINS IL, ESPECIALLY THE IL-1, IL-2, IL-3, IL-4, IL-5, IL-6, IL-7, IL-8, IL-9, IL-10 AND IL-11 SUBTYPES THEREOF; COLONY STIMULATING FACTORS, NAMELY, GRANULOCYTE-MACROPHAGE COLONY STIMULATING FACTOR, GRANULOCYTE-COLONYSTIMULATING FACTOR, ALPHA AND BETA FORMS, AND MACROPHAGE-COLONY STIMULATING FACTOR, ALSO KNOWN AS CSF-1; HAEMOPOIETINS, NAMELY, ERYTHROPOIETIN, HAEMOPOIETIN-ALPHA AND KIT-LIGAND, ALSO KNOWN AS STEM CELL FACTOR OR STEEL FACTOR; INTERFERONS IFNS, NAMELY, IFNALPHA, IFNBETA,IFNGAMMA; GROWTH FACTORS AND BIFUNCTIONAL GROWTH MODULATORS, NAMELY, EPIDERMAL GROWTH FACTOR, PLATELET-DERIVED GROWTH FACTOR, TRANSFORMING GROWTH FACTOR, ALPHA AND BETA FORMS, AMPHIREGULIN, SOMATOMEDIN-C, BONE GROWTH FACTOR, FIBROBLAST GROWTH FACTORS, INSULIN-LIKE GROWTH FACTORS, HERAPIN BINDING GROWTH FACTORS AND TUMOR GROWTH FACTORS; DIFFERENTIATION FACTORS AND THE LIKE, NAMELY, MACROPHAGE DIFFERENTIATING FACTOR, DIFFERENTIATION INDUCING FACTOR DIF AND LEUKAEMIAINHIBITORY FACTOR; ACTIVATING FACTORS, NAMELY, PLATELET ACTIVATING FACTOR; COAGULATION FACTORS SUCH AS FIBRINOLYTIC/ANTICOAGULANT AGENTS INCLUDING HERAPIN AND PROTEASES AND THEIR PRO-FACTORS, NAMELY, CLOTTING FACTORS VII, VIII, IX, X, Xl, XII, ANTITHROMBIN Ill, PROTEIN C, PROTEIN 5, STREPTOKINASE, UROKINASE, PROUROKINASE, TISSUE PLASMINOGEN ACTIVATOR, FIBRINOGEN AND HIRUDIN; PEPTIDEHORMONES, NAMELY, INSULIN AND CALCITONIN; ENZYMES NAMELY, SUPEROXIDE DISMUTASE, GLUCOCEREBROSIDASE, ASPARAGINASE AND ADENOSINE DEAMINASE; TRANSCRIPTION FACTORS AND TRANSCRIPTIONAL MODULATORS; CARBOHYDRATES, GLYCOSOAMINOGLYCANS, GLYCOPROTEINS AND POLYSACCHARIDES; LIPIDS, NAMELY, PHOSPHATI DYL-ETHANOLAMINE, PHOSPHATIDYLSERINE AND DERIVATIVES THEREOF; SPHINGOSINE; STEROIDS, NAMELY, CHOLESTEROL AND DERIVATIVES THEREOF; NUCLEOTIDES, NUCLEOSIDES, HETEROCYCLIC BASES, DNA, RNA, SYNTHETIC AND NON-SYNTHETIC OLIGONUCLEOTIDES INCLUDING THOSE WITH NUCLEASE RESISTANT BACKBONES; VITAMINS; ANTIBIOTICS; BACTERISTATIC AND BACTERICIDAL AGENTS; ANTIFUNGAL, ANTHELMINTHIC AND OTHER AGENTS EFFECTIVE AGAINST INFECTIVE AGENTS INCLUDING UNICELLULAR PATHOGENS; SMALL EFFECTOR MOLECULES, NAMELY, NORADRENALIN, ALPHA ADRENERGIC RECEPTOR LIGANDS, DOPAMINE RECEPTOR LIGANDS, HISTAMINE RECEPTOR LIGANDS, GABNBENZODIAZEPINE RECEPTOR LIGANDS, SEROTONIC RECEPTOR LIGANDS, LEUKOTRIENES AND TRIIODOTHYRONINE; CYTOTOXIC AGENTS SUCH AS DOXORUBICIN, METHOTREXATE AND DERIVATIVES THEREOF; VACCINES, NAMELY, HEPATITIS-B VACCINE, MALARIA VACCINE, MELANOMA VACCINE AND HIV-1 VACCINE

CATHETERS; STENTS AND PARTS AND FITTINGS FOR THESE GOODS

TECHNOLOGY LICENSING SERVICES RELATING TO PHARMACEUTICALS, VETERINARY PRODUCTS, SANITARY PRODUCTS, GENE THERAPY, CANCER TREATMENT AND POLYMER TECHNOLOGY

RESEARCH AND CONSULTANCY SERVICES RELATING TO PHARMACEUTICALS, VETERINARY PRODUCTS, SANITARY PRODUCTS, GENE THERAPY, CANCER TREATMENT AND POLYMER TECHNOLOGY